App
International Edition

Sunday

April 30, 2017

Breaking News, World News and Taiwan News.
About Us
App
Advertise
Contact Us
MOST READ
1
Trump rejects Tsai's suggestion of second call
2
How I survived
3
Taiwan teachers to learn more about Holocaust
4
New China fears brew in Taiwan after snub
5
Terry Gou confirms US investment push after another White House visit
More
More Health Topics
  Aging    AIDS    Allergies    Arthritis-Pains    
  Cancer    Children’s Health    Cold-Flu    
  Diabetes    Eye Health    Genetics    Heart    
  Hypertension    Infectious Diseases    
  Mental Health    
  Nutrition-Fitness    Oral Hygiene     
  Sexual Health     Skin-Beauty     
  Pregnancy-Menopause    Stroke    
  Surgical News    Other    
 
 
Health > Medicine
A new drug compound could lead to a breakthrough in the fight against bovine spongiform encephalopathy, the incurable brain-wasting disease also known as mad cow disease, researchers said Wednesday.
 
US regulator approves first drug made with 3D printer
The U.S. Food and Drug Administration said Tuesday it has approved the first drug made with a 3D printer -- pills for treating epilepsy.
 
A dengue vaccine candidate by French drugmaker Sanofi protects more than three quarters of participants, an analysis found Monday.
 
European Union nations have until Aug. 20 to suspend the sale of some 700 generic drugs made in India, the EU's executive confirmed Monday.
 
Defective or 'leaky' vaccines may lead to even more powerful viruses, according to a study on poultry that raises concerns about vaccine development in humans.
 
The U.S. Food and Drug Administration (FDA) on Friday approved a first-of-a-kind drug that lowers artery-clogging cholesterol more than older drugs that have been prescribed for decades.
 
An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration (FDA)of the U.S., adding to the surge of new options -- all much more effective but extremely costly -- for patients with the liver-destroying virus.
 
An experimental drug for one of the hardest-to-treat types of hepatitis C has been approved by the Food and Drug Administration (FDA) of the U.S., adding to the surge of new options -- all much more effective but extremely costly -- for patients with the liver-destroying virus.
 
The BioBusiness Asia (BBA) conference, one of the Bio Taiwan 2015 highlights, opened in Taipei Wednesday, attended by business, government and academic representatives in the bio technology sector from countries in the Asia-Pacific region.
 
Older women with mild memory impairment worsened about twice as fast as men, U.S. researchers reported Tuesday, part of an effort to unravel why women are especially hard-hit by Alzheimer's.
 
Calendar  
  
1   2   3   4   5   6   7   8   9   10    <   Prev    Next   >
Subscribe  |   Advertise  |   RSS Feed  |   About Us  |   Career  |   Contact Us
Sitemap  |   Top Stories  |   Taiwan  |   China  |   Business  |   Asia  |   World  |   Sports  |   Life  |   Arts & Leisure  |   Health  |   Editorial  |   Commentary
Travel  |   Movies  |   TV Listings  |   Classifieds  |   Bookstore  |   Getting Around  |   Weather  |   Guide Post  |   Student Post  |   Terms of Use  |   Sitemap
  chinapost search
X